Abstract
Hypoxia-Inducible Factor (HIF) transcription factors are heterodimeric proteins involved in the regulation of oxygen homeostatis. Their upregulation has been related to several tumors with a remarkably poor clinical outcome. The recent discovery of a druggable cavity in the HIF-2α PAS-B domain has opened an unprecedented opportunity for targeting the HIF-2α transcription factor in view of pharmaceutical strategies. Coincidentally, a novel compound able to selectively disrupt the HIF heterodimerization with a submicromolar activity has been reported. In this work, we investigated the molecular mechanisms responsible for the inhibition by comparing the dynamical features of the HIF-2α PAS-B monomer and the HIF- 2a PAS-B/HIF-1β PAS-B complex, in the ligand-bound and -unbound states. Plain and biased Molecular Dynamics were used to characterize the differential conformational changes both structurally and energetically. © 2014 Masetti et al.
Cite
CITATION STYLE
Masetti, M., Falchi, F., & Recanatini, M. (2014). Protein dynamics of the HIF-2α PAS-B domain upon heterodimerization and ligand binding. PLoS ONE, 9(4). https://doi.org/10.1371/journal.pone.0094986
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.